Placebo News and Research

RSS
Rhythm, Actavis announce initiation of relamorelin Phase 2b trial for treatment of diabetic gastroparesis

Rhythm, Actavis announce initiation of relamorelin Phase 2b trial for treatment of diabetic gastroparesis

Exercise benefits obese, overweight people with NAFLD

Exercise benefits obese, overweight people with NAFLD

US health care providers reluctant to prescribe HIV prevention plan

US health care providers reluctant to prescribe HIV prevention plan

Medinatura now offers Traumeel and Zeel injections for knee OA

Medinatura now offers Traumeel and Zeel injections for knee OA

Outpatient treatments with fewer injections produce similar results to standard treatment course

Outpatient treatments with fewer injections produce similar results to standard treatment course

Researchers test effects of light therapy on brain function

Researchers test effects of light therapy on brain function

Columbia Laboratories to adopt Juniper Pharmaceuticals brand marks

Columbia Laboratories to adopt Juniper Pharmaceuticals brand marks

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

Emmaus Life Sciences presents Phase 3 clinical trial of PGLG treatment for sickle cell disease

Emmaus Life Sciences presents Phase 3 clinical trial of PGLG treatment for sickle cell disease

New blood test promises to detect food allergies

New blood test promises to detect food allergies

Folic acid supplements can improve blood vessel dilation in older adults

Folic acid supplements can improve blood vessel dilation in older adults

MOVANTIK (naloxegol) now available in U.S. for treatment of OIC in adult patients with non-cancer pain

MOVANTIK (naloxegol) now available in U.S. for treatment of OIC in adult patients with non-cancer pain

PAION initiates Remimazolam Phase 3 trial in patients undergoing colonoscopy

PAION initiates Remimazolam Phase 3 trial in patients undergoing colonoscopy

New analysis raises questions about common use of antidepressant drugs for anxiety disorders

New analysis raises questions about common use of antidepressant drugs for anxiety disorders

Investigational S-equol nutritional supplement may alleviate certain menopause symptoms

Investigational S-equol nutritional supplement may alleviate certain menopause symptoms

Can-Fite BioPharma's CF101Phase II/III psoriasis trial fails to meet primary endpoint

Can-Fite BioPharma's CF101Phase II/III psoriasis trial fails to meet primary endpoint

DURECT initiates DUR-928 multi-dose Phase 1 clinical trial for NAFLD, NASH and AKI

DURECT initiates DUR-928 multi-dose Phase 1 clinical trial for NAFLD, NASH and AKI

Synageva announces submission of Kanuma application to Cofepris for treatment of LAL Deficiency

Synageva announces submission of Kanuma application to Cofepris for treatment of LAL Deficiency

Clonidine Topical Gel fails to meet primary endpoint in Phase 3 study for treatment of painful diabetic neuropathy

Clonidine Topical Gel fails to meet primary endpoint in Phase 3 study for treatment of painful diabetic neuropathy

Naldemedine meets primary and secondary endpoints in phase III study for OIC treatment

Naldemedine meets primary and secondary endpoints in phase III study for OIC treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.